Top 11 macrogenics.com competitors & alternatives
[MacroGenics – Developing innovative antibody-based cancer therapeutics Macrogenics - Homepage]
macrogenics.com competitors and alternatives
Top 11 macrogenics.com competitors and alternatives are ranked by similar search terms, traffic and worth.
macrogenics.com's top 5 competitors are: incyte.com with 283 daily traffic and 111,200 estimated worth, trialnet.org with 0 daily traffic and 20,300 estimated worth, xencor.com with 105 daily traffic and 17,800 estimated worth, immunogen.com with 0 daily traffic and 14,700 estimated worth, innate-pharma.com with 0 daily traffic and 12,200 estimated worth.
incyte.com
Biopharmaceutical Company | Solutions for Unmet Medical Needs | Incyte.com
Incyte is a global biopharmaceutical company focused on finding innovative solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines..
Daily Traffic: 283
Website Worth: $ 111,200
immunogen.com
ImmunoGen | Target a Better Now | ADC Technology-Focused Cancer Treatment
Target a better now with ImmunoGen, Inc., a biotechnology company focused on the development of antibody-drug conjugate (ADC) technology to treat cancer.
Daily Traffic: 0
Website Worth: $ 14,700
syros.com
Syros.com - Discover the Beauty of Syros Island, Greece
Explore Syros.com for comprehensive travel guides, accommodation options, and attractions on Syros Island, Greece. Plan your perfect holiday today!
Daily Traffic: 90
Website Worth: $ 10,500
creativebiolabs.net
Recombinant Antibodies, Single Domain Antibodies, Biosimilars - Creative Biolabs
Creative Biolabs, a leading supplier of recombinant antibodies, develops a wide range of antibodies from therapeutic antibodies and single domain antibodies to bispecific antibodies and intrabodies.
Daily Traffic: 0
Website Worth: $ 0
sugarconebiotech.com
SugarCone Biotech R & D - Analysis, Consulting, Investment
Research & development consultant, corporate & program development plans, funding, investment & value inflection strategy, program execution & competitive analysis, Boston
Daily Traffic: 0
Website Worth: $ 0
bispecific.com
Home | 12th Annual World Bispecific Summit | September 2021, Online
The 15th World Bispecific Summit is the Only Meeting Dedicated Solely to the Discovery and Optimization of Next Generation Bi, Tri - and Multispecific Drugs
Daily Traffic: 0
Website Worth: $ 0
tesarobio.com
Tesaro is now part of GSK | GSK
Tesaro is now part of GSK where we continue to focus on delivering transformational therapies for cancer patients.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like macrogenics.com